Evidence map›Paper›PMID 40504263›Full record

ArticleThe American journal of gastroenterology2025

DRESS Syndrome in Patients With Drug-Induced Liver Injury: Characteristics and HLA Risk Factors.

Sahand Rahnama-Moghadam, Nitin Arora, Raj Vuppalanchi, Yi Ju Li, Jiezhun Gu, Huiman Barnhart, Elizabeth Phillips, Naga Chalasani, Drug Induced Liver Injury Network

Abstract read
In one paragraph

Article in The American journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. [Research advances on the role of eosinophils in acute liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  2. Article
  3. Article
  4. [Research progress in the field of drug-induced liver injury in 2025].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sahand Rahnama-MoghadamIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0003-1323-5944
Nitin AroraIndiana University School of Medicine, Indianapolis, Indiana, USA.
Raj VuppalanchiIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0003-0637-1577
Yi Ju LiDuke University, Durham, North Carolina, USA.ORCID 0000-0001-6996-4834
Jiezhun GuDuke University, Durham, North Carolina, USA.
Huiman BarnhartDuke University, Durham, North Carolina, USA.ORCID 0000-0003-0988-3439
Elizabeth PhillipsVanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0002-7623-3383
Naga ChalasaniIndiana University School of Medicine, Indianapolis, Indiana, USA.
Drug Induced Liver Injury Network

Funding

Drug Induced Liver Injury Network Data Coordinating CenterU01DK065176 · NIDDK · DUKE UNIVERSITY · PI Huiman X Barnhart · 2003 to 2026
$25.5M
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)U24DK065176 · NIDDK · DUKE UNIVERSITY · PI BARNHART, HUIMAN X · 2018 to 2022
$7.6M
IU Clinical Center: Drug Induced Liver Injury NetworkU01DK065211 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI NAGA P CHALASANI · 2003 to 2026
$7.5M
University of North Carolina Clinical Center for DILINU01DK065201 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PAUL B WATKINS · 2003 to 2026
$7.3M
Michigan Hepatotoxicity Clinical Research Network Renewal 2018U01DK065184 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERT J FONTANA · 2003 to 2026
$7.0M
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and DietarySupplementsU01DK083027 · NIDDK · THOMAS JEFFERSON UNIVERSITY · PI Dina Halegoua-DeMarzio · 2008 to 2026
$7.0M
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.U01DK083020 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Lily Dara · 2008 to 2026
$5.9M
Mount Sinai Regional Drug Induced Liver Injury Network SiteU01DK100928 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AHMAD, JAWAD, ODIN, JOSEPH · 2013 to 2022
$4.0M
NIDDK NIH HHS U01 DK065176NIDDK NIH HHS U01 DK065184NIDDK NIH HHS U01 DK065201NIDDK NIH HHS U01 DK065211NIDDK NIH HHS U01 DK083020NIDDK NIH HHS U01 DK083027NIDDK NIH HHS U01 DK100928NIDDK NIH HHS U24 DK065176
6 · The paper itself

Abstract

introductionDrug reaction with eosinophilia and systemic symptoms (DRESS) can sometimes occur in patients with drug-induced liver injury (DILI). However, detailed studies of DRESS in patients with DILI from the United States are lacking. We investigated the characteristics and human leukocyte antigen (HLA) risks for DILI who also developed DRESS.

methodsPatients with definite, highly likely, or probable DILI enrolled into US DILI Network studies between September 2004 and August 2023 were included. DRESS was defined based on modified RegiSCAR criteria. HLA alleles were compared between DILI-DRESS cases and 2 control groups (DILI with non-DRESS rash [n = 244] and DILI without rash [n = 1,637]).

resultsOf 2,121 participants with DILI during the study period, 128 participants had DRESS (6%). The most frequently implicated drugs causing DRESS were trimethoprim/sulfamethoxazole, lamotrigine, phenytoin, allopurinol, and vancomycin. Compared with 1993 patients with DILI without DRESS, patients with DILI + DRESS were younger (mean age 42.3 years vs 50.6 years), were more likely to be Black (26% vs 12%), and had shorter latency (median 31 days vs 47 days), higher frequency of rash (100% vs 13%), eosinophilia (55% vs 13%), and fever (76% vs 16%) ( P < 0.001 for all). Compared with DILI without DRESS, DILI + DRESS had more severe liver injury (severe/fatal: 45% vs 21.5%, P < 0.001) and higher overall (15.6% vs 6.3%, P < 0.001) and liver-related (9% vs 2.3%, P < 0.001) mortality. HLA A*32:01 , HLA B*53:01 , and HLA B*58:01 were significantly enriched in DILI-DRESS cases, compared with control groups. DISCUSSION: Patients with DILI and DRESS are younger, are more likely to be Black, have shorter time to DILI onset with more severe liver injury and higher overall and liver-related mortality. HLA A*32:01 , HLA B*53:01 , and HLA B*58:01 are risk factors for DILI-DRESS.

Indexed as

DILIDRESSLamotriginePhenytoinTrimethoprim-Sulfamethoxazole

Identifiers

PMID40504263
PMCPMC12715855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.